Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis.
about
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer.
P2860
Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Abiraterone acetate after prog ...... center retrospective analysis.
@ast
Abiraterone acetate after prog ...... center retrospective analysis.
@en
type
label
Abiraterone acetate after prog ...... center retrospective analysis.
@ast
Abiraterone acetate after prog ...... center retrospective analysis.
@en
prefLabel
Abiraterone acetate after prog ...... center retrospective analysis.
@ast
Abiraterone acetate after prog ...... center retrospective analysis.
@en
P2093
P2860
P1433
P1476
Abiraterone acetate after prog ...... center retrospective analysis.
@en
P2093
Akihiro Yano
Hiroji Uemura
Hiroyoshi Suzuki
Ken-Ichi Tabata
Naoto Kamiya
Nobuaki Matsubara
Satoru Kawakami
Takashi Kawahara
Takefumi Satoh
Yoko Yamada
P2860
P2888
P356
10.1186/S13104-016-2279-9
P577
2016-10-18T00:00:00Z
P6179
1004797471